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Abstract
BACKGROUND: Humanmesenchymal stem/stromal cells (hMSCs) are at the forefront of regenerativemedicine applications due
to their relatively easy isolation and availability in adults, potential to diﬀerentiate and to secrete a range of trophic factors
that could determine specialised tissue regeneration. To date, hMSCs have been successfully cultured in vitro on substrates
such as polystyrene dishes (TCPS) or microcarriers. However, hMSC sub-cultivation and harvest typically employs proteolytic
enzymes that act by cleaving important cell membrane proteins resulting in long-term cell damage. In a process where the cells
themselves are the product, a non-enzymatic and non-damaging harvesting approach is desirable.
RESULTS: An alternative system for hMSC expansion and subsequent non-enzymatic harvest was investigated here. A liq-
uid/liquid two-phase system was proposed, comprising a selected perﬂuorocarbon (FC40) and growth medium (DMEM). The
cells exhibited similar cell morphologies comparedwith TCPS. Moreover, they retained their identity and diﬀerentiation poten-
tial post-expansion and post-harvest. Further, no signiﬁcant diﬀerence was foundwhen culturing hMSCs in the culture systems
prepared with either fresh or recycled FC40 perﬂuorocarbon.
CONCLUSIONS: These ﬁndings make the FC40/DMEM system an attractive alternative for traditional cell culture substrates due
to their ease of cell recovery and recyclability, the latter impacting on overall process costs.
© 2017 The Authors. Journal of Chemical Technology&Biotechnology published by JohnWiley & Sons Ltd on behalf of Society of
Chemical Industry.
Supporting informationmay be found in the online version of this article.
Keywords: human bone marrow-derived mesenchymal stem/stromal cells (hMSCs); two-phase system; liquid/liquid interface; perﬂuo-
rocarbons; expansion
INTRODUCTION
Human mesenchymal stem/stromal cells (hMSCs) are at the fore-
front of regenerative medicine applications due to their relatively
easy isolation and availability in adults, potential to diﬀerentiate
into the three lineages (i.e. adipogenesis, chondrogenesis and
osteogenesis) and the secretion of a range of trophic factors
that could determine specialised tissue regeneration.1 Similarly
to other adherent cell types, hMSCs can be expanded in vitro
on solid cell culture substrates such as polystyrene dishes2,3
or micrometer-sized beads (i.e. microcarriers).4–7 While cell
attachment to substrates is advantageous for cell expansion,
cell detachment from the same substrates may become a major
challenge as cell viability and functionality post-harvest has
to remain intact. Cell detachment and subsequent recovery
is at the moment probably one of the most important engi-
neering factors that is hindering the faster development of
cell-based therapies. Over the years, numerous cell detach-
ment strategies have been developed and these span a wide
range of techniques adapted for diﬀerent purposes and prac-
tical applications. Current cell harvesting methods make use
of diﬀerent cues, such as: mechanical (e.g. cell scraping,8 shear
ﬂow9), chemical (e.g. enzymes,10 chelators11), magnetic12 or even
stimuli-responsive (e.g. thermo-responsive,13,14 pH-responsive,15
electro-responsive,16,20 photo-responsive17).
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The most common method for cell harvesting is enzyme diges-
tion with particular reference to the proteolytic enzyme, trypsin or
its derivatives. This method consists of the addition of an active
concentration of enzyme to the cell culture system that works
by cleaving the integrin–ligand bonds that mediate cell attach-
ment to the given substrate.18,19 This method provides an eﬃcient
way to break cell–surface and cell–cell interactions and is advan-
tageous for applications requiring single cell suspensions rather
than cell sheets. However, enzymatic treatment is an invasive
approach and even though a promising technique has recently
been developed,20 in the long term, it can potentially have dam-
aging eﬀects on the cells themselves by aﬀecting critical cell mem-
brane proteins.18,19 A non-enzymatic and non-invasive harvesting
approach could potentially oﬀer advantages for the overall cell
expansion process.
To overcome the deﬁciencies of the enzymatic method, alterna-
tive detachmentmethods havebeendeveloped. However, despite
having some advantages over enzymatic treatments, these meth-
ods can be complicated, not necessarily scalable and potentially
not of economic value. For example, electrochemically-induced
detachment can achieve cell detachment within minutes; how-
ever, it requires the elaborate fabrication of sensor features and
often costly specialised coatings.16,21 Another example of eﬃ-
cient cell detachment was from photo-sensitive substrates result-
ing in >90% viable cells detached.21,22 Despite their potential, this
method can induce an irreversible modiﬁcation of the substrate
that impedes recycling of the material which can be expensive as
it typically requires the synthesis of complicated substrates. More-
over, the use of UV as a stimulus for cell detachment could poten-
tially have amutagenic eﬀect (dimerization of thyminemolecules)
on the cells.
Ideally, a simple, non-complicated, non-enzymatic, non-invasive,
scalable and cost-eﬀective approach to cell detachment should
be implemented. As such, here we proposed and investigated a
liquid/liquid two phase system comprising a selected perﬂuoro-
carbon and growth medium for the expansion and recovery of
viable and fully functional hMSCs. As part of this study, we have
recently published a paper on the process engineering aspects of
using perﬂuorocarbon/DMEM systems for stem cell culture and
this work builds on that earlier study.23 Perﬂuorocarbon liquids
are ﬂuorine-substituted hydrocarbons with exceptional chemical
and thermal stabilities, low surface tensions and speciﬁc gravi-
ties of about twice that of water.23 Perﬂuorocarbons have been
intensively used inbiomedical applications for almost twodecades
for biomedical imaging under the form of nano-emulsions24,25 or
even biomedical therapeutics as an artiﬁcial, intravascular oxygen
carrier.26,27 Other biomedical applications include lung surfactant
replacement27,28 and ophthalmologic aids.27,29 For cell and tissue
culture systems, a series of beneﬁts of usingperﬂuorocarbonshave
been identiﬁed which include easy sterilisation, chemical and bio-
logical inertness, recoverability and recyclability, scavengers for
gaseous cellular products and the ability to form two-phase liq-
uid/liquid systems.30,31
When anchorage-dependent cells are inoculated in the perﬂuo-
rocarbon/mediumtwo-phase system, cellsmigrate to the interface
where theyattach, spreadandgrow. Several typesof adherent cells
have been successfully cultured to date, including ﬁbroblasts,32–34
melanoma cells,35 epidermal carcinoma cells32 ormyoblasts.32 The
non-enzymatic cell harvest approach when employing such a sys-
tem consisted of simple pipetting,34 centrifugation33 or interface
aspiration.32 The latter two are scalable to much larger systems.
To the best of our knowledge, no studies on stem cell growth
in a perﬂuorocarbon/medium two-phase system have been pub-
lished. Moreover, the potential of such a system to be used as a
stem cell expansion and non-enzymatic harvest system is depen-
dent on whether stem cell quality is retained at the end of culture
and post-harvest.
MATERIALS ANDMETHODS
Cell culture on TCPS
Three human bone marrow-derived human mesenchymal stem
cells, identiﬁed here as M0, M2 and M4 (Lonza, Germany) were
obtained from three diﬀerent healthy donors of diﬀerent age, sex
and ethnicity (Supplementary Table 1), after the patient’s informed
consent. For all the experiments, hMSCs between passages 2 to
6 were used. The cells were cultured according to previously
determined protocols.2,5,7 Brieﬂy, the cells were seeded at 5000
cells cm−2 and grown on tissue culture plastic (TCPS) (NUNC,
ThermoFisher, UK) in DMEM supplemented with 10% (v/v) foetal
bovine serumand 2mmol L−1 ultra-glutamine (Lonza, UK). Growth
medium was replaced every 3 days and the cells were passaged
every 6 days. During passage, the hMSCs were ﬁrst washed with
Ca2+ and Mg2+ free phosphate buﬀered saline (PBS) (Lonza, UK).
Cell detachment from the TCPS was achieved by incubating with
0.25% (w/w) trypsin/EDTA (Invitrogen, UK) for 7 min at 37∘C
and 5% CO2 in a humidiﬁed incubator. The enzyme was then
inactivated by the addition of pre-warmed growth medium and
the cell suspension was centrifuged at 220 g for 5 min at room
temperature. The obtained cell pellet was then resuspended in an
appropriate volume of culture medium. Cells were counted and
cell numbers were seeded as required for each experiment.
Preparation of the liquid/liquid interface
Fluorinert FC40 (3M, SigmaAldrich, UK)was used for the formation
of the two-phase systems to be used as cell culture substrates. The
main physical properties of Fluorinert FC40 are listed in Table 1. Ini-
tially, the perﬂuorocarbon was sterilised by autoclaving at 121∘C
and 2 atm for 15 min. After use, the perﬂuorocarbon was recov-
ered, recycled and re-sterilised by vacuum ﬁltration through a 0.2
μm ﬁlter unit (Millipore, UK). For all experiments, ultralow attach-
ment 6 and 24-well plates (Corning, UK) were employed to ensure
cell attachment was only achieved on the tested substrates and
not the plastic. For the preparation of the two-phase systems,
the perﬂuorocarbon FC40 was ﬁrst added to the well plate, fol-
lowed by the gentle addition of the growth medium so it formed
a layer on top of the perﬂuorocarbon. A 1:2 ratio of perﬂuorocar-
bon to growthmediumwas used for all experiments. For example,
in the 24-well plates, 1 mL of perﬂuorocarbon was topped up
with 2 mL of growth medium to ensure the formation of a ﬂat
interface.
Cell culture on the liquid/liquid interface
The formation of the two-phase system is based on mutual insol-
ubility and density diﬀerence between the perﬂuorocarbon and
the medium. Here the perﬂuorocarbon formed the bottom phase
and the growth medium formed the top phase with cells grow-
ing at the interface. Before cell inoculation, the perﬂuorocarbon
was conditioned in the growth medium at 37∘C and 5% CO2 in a
humidiﬁed incubator for at least 2 h. This conditioning step allows
serum proteins to deposit on the liquid/liquid interface, thus facil-
itating cell adhesion to the ﬂexible interface. hMSCs were again
seeded at 5000 cells cm−2 of interfacial area and were kept in
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Table1. Mainphysical properties of the liquid phases involved in the
formation of the two-phase systems
Liquid
Chemical
structure
Density
(g mL−1)
Viscosity
(at 25∘C) (cSt)
Surface tension
(dyn cm−1)
Fluorinert FC40 N(C4F9)3 1.85 2.2 16
DMEM - 1.02 1 72
culture for up to 10 days depending on the experiment. Every 3
days in culture, a partial medium exchange was performed. For
each individual experiment, a control experiment was conducted
in parallel by culturing cells on TCPS without perﬂuorocarbon. For
post-expansion characterisation, the cells cultured on the inter-
face of the FC40/DMEM system were harvested with trypsin to
achieve a single cell suspension. Brieﬂy, the spent medium was
collected and replaced with pre-warmed Ca2+ and Mg2+-free PBS,
followed by incubation in 1mL of pre-warmed 0.25% trypsin-EDTA
solution at 37∘C and 5% CO2 for 5 min in a humidiﬁed incuba-
tor. The single cell suspension was collected and a cell pellet was
obtained by centrifugation at 220 g for 5 min.
Analytical techniques
Cell morphology was assessed by phase contrast on a Nikon
Ti Eclipse microscope and by Live/Dead (Calcein AM/ Ethidium
Homodimer) Viability/Cytotoxicity kit (Life Sciences, ThermoFisher,
UK) visualized on a Nikon Ti Eclipse epi-ﬂuorescence microscope.
The Live/Dead staining was performed following the manufac-
turer’s instructions. Brieﬂy, the cells were ﬁrst washed with PBS
and then incubated with the Live/Dead stain containing a ﬁnal
concentration of 2 μmol L−1 calcein-AM and 4 μmol L−1 ethidium
homodimer in the dark at 37∘C and 5% CO2 for 40 min. After incu-
bation, the Live/Deadworking solutionwas removed and replaced
with PBS. Cell counts and viability (via propidium iodide exclusion)
were performed using the Nucleocounter NC-3000 (Chemometec,
UK). 1 mL spent medium samples were collected at diﬀerent time
points in culture to assess the metabolic activity of the cells in dif-
ferent conditions. The samples were stored at –20∘C until analysis.
When needed, medium samples were thawed, randomized and
analysed for glucose, lactate and ammonia concentrations. Fresh
growth medium samples were used as baseline control. Sample
analysis was done on the Cedex Bio HT analyser (Roche, Germany).
Based on cell counts and metabolic measurements, the following
parameters were calculated:
1. Speciﬁc growth rate
𝜇 =
ln
(
Cx(t)∕Cx(0)
)
Δt
(1)
where 𝜇 is the speciﬁc growth rate (h−1), Cx(t) and Cx(0) represent
cell numbers at the end and start of the exponential growth, t
represents time in culture (h).
2. Doubling time
td = ln 2
𝜇
(2)
where td is doubling time (h) and 𝜇 is the speciﬁc growth
rate (h−1).
3. Fold increase
FI =
Cx
(
f
)
Cx (0)
(3)
where Cx(f ) represents the maximum cell number and Cx(0) is the
initial cell number.
4. Speciﬁc metabolite production/consumption rate
qmet = 𝜇
Cx (0)
x
Cmet (t) − Cmet (0)
e𝜇t − 1
(4)
where qmet represents the speciﬁc metabolite production/
consumption rate (mol/cell/day), Cmet(t) and Cmet(0) are the
metabolite concentrations at the endand the start of the exponen-
tial growth, respectively, Cx(0) represents the cell number at the
start of the exponential growth phase and t is time in culture (h).
Proliferation assessment
For this experiment, only M0 and M2 cell lines were used for pro-
liferation assessment. During the last 24 h culture, the cells were
pulsed with EdU (5-ethynyl-2’-deoxyuridine). EdU is a nucleoside
analogue of thymidine and is incorporated into DNA during active
DNA synthesis, thus allowing for the detection of cells entering
the S-phase of their cycle. After 72 h, the culture was stopped and
the cells were processed following the manufacturer’s protocol
for the Click-iT EdU AlexaFluor 488 kit (Life Technologies, Ther-
moFisher, UK). Imaging was performed on a Nikon Ti Eclipse ﬂu-
orescence microscope. EdU quantiﬁcation was done using the
ImageJ software (NIH) by counting the number of DAPI stained
nuclei (blue) and nuclei positive for EdU (green). The results were
averaged from three independent experiments and aminimum of
300 nuclei were counted for each condition.
Immuno-phenotype analysis
Immuno-phenotype analysis was performed before and after
hMSC expansion on the FC40/DMEM interface. hMSC immune-
phenotype was determined by multi-parameter ﬂow cytometry
by using a previously developed protocol.3 Brieﬂy, cells were
harvested from the substrate as described previously, counted
and the cell suspension concentrated to achieve 1× 106cellsmL−1.
200 𝜇L of cell suspension was then loaded onto a V-bottom 96
well plate and centrifuged at 220 g for 5 min. The supernatant
was then aspirated, the cell pellet resuspended in ﬂow cytometry
staining buﬀer (R&D Systems, UK) and centrifuged again. The
cells were stainedwithmouse anti-humanmonoclonal antibodies
(BD Biosciences, UK) for 30 min in the dark at room temperature.
The ﬂuorescently-labelled antibodies were selected based on a
panel recommended by the International Society for Cell Therapy
(ISCT)22 and these were: CD73 (PE-Cy7), CD90 (APC), CD105 (PE),
CD34 (PE-Cy5) and HLA-DR (FITC). After incubation, the samples
were washed twice with staining buﬀer as described before. The
stained samples were then analysed on the Guava EasyCyte 8HT
ﬂow cytometer (Merck Millipore, UK) equipped with 488 nm and
640 nm excitation lasers. A minimum of 10 000 gated events were
recorded for each sample. Post-acquisition analysis and com-
pensation were performed using the FlowJo software (Treestar
Inc, USA).
Immunoﬂuorescence staining
For immunoﬂuorescence experiments, cells were seeded at
10 000 cells cm−2 of interfacial/surface area. At the desired time
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TCPS
A
B TCPS FC40/DMEM
FC40/DMEM
Figure 1. (A) M0 and (B) M2 hMSCs seeded at 5000 cells cm−2 on TCPS and the FC40/DMEM interface, after 72 h in culture. Scale bar represents 500 μm.
points in culture, cells were ﬁxed with 4% (v/v) para-formaldehyde
at room temperature for 30 min, followed by washing twice
with staining buﬀer (Biolegend, UK). Non-speciﬁc binding and
staining was blocked with blocking buﬀer containing 10% v/v
normal goat serum (ThermoFisher, UK) at room temperature for
45 min. The blocking buﬀer was then removed and the rabbit
anti-paxillin primary antibody (Y113) (Abcam, UK) was added at
a 1:100 dilution and incubated at 2–8∘C overnight. The primary
antibody solution was then removed, samples washed twice with
staining buﬀer. The goat polyclonal secondary antibody to rabbit
IgG (AlexaFluor 488 conjugated) (Abcam, UK) was then added
at a 1:200 dilution and incubated at room temperature for 2 h.
Following two washes, the actin ﬁlaments were stained with
AlexaFluor-546 phalloidin (Life Technologies, ThermoFisher, UK)
following themanufacturer’s protocol. Cells were incubated in the
Phalloidinworking solution at room temperature in the dark for 20
min, followed by two washes with PBS. Nuclei were stained with
DAPI (Life Technologies, ThermoFisher, UK) (300 nmol L−1 working
solution) at room temperature in the dark for 5 min. Samples were
visualised on a Nikon Ti Eclipse ﬂuorescence microscope.
Diﬀerentiation potential assessment
All chemicals were obtained from Sigma Aldrich (UK) unless
otherwise stated. Diﬀerentiation studies were performed before
and after cell expansion on the FC40/DMEM interface by follow-
ing well established protocols.3,7 hMSC diﬀerentiation into the
three lineages was induced by using the complete diﬀerentia-
tion kits StemPro (ThermoFisher, UK). Brieﬂy, for adipogenic and
osteogenic diﬀerentiation, cells were seeded in growth medium
at 5000 cells cm−2 in 12-well plates, allowed to attach and prolifer-
ate for 24–48 h until 70–80% conﬂuency was achieved and then
the growth medium was replaced with diﬀerentiation medium.
For chondrogenic diﬀerentiation, a cell pellet was generated by
centrifugation at 220 g for 5 min, followed by re-suspension to
achieve a 1× 107 cells mL−1 concentration. 5 𝜇L droplets of the
concentrated cell suspension were then plated in empty 12-well
plates and incubated at 37∘C and 5% CO2 in a humidiﬁed incuba-
tor for 1–2 h to allow cell attachment, after which 2 mL of chon-
drogenesis diﬀerentiation medium was gently added to the wells
to avoid disturbing the macro-masses. Diﬀerentiation medium
was changed every 3–4 days and cells were cultured for 21 days.
After 21 days, cells were washed and ﬁxed for 30 min with 4%
(v/v) para-formaldehyde at room temperature. Adipocytes were
stained with Oil Red O. Brieﬂy, initially a stock solution of 0.3%
(w/v) Oil Red O in 99% isopropanol was prepared. For adipocyte
staining, 3 parts of the Oil Red O stock was mixed with 2 parts
distilled water and incubated at room temperature for 10 min,
followed by two washes with distilled water. Chondrocytes were
stained with 1% (w/v) Alcian Blue in 0.1 N HCl solution for 60 min,
washed twice with 0.1 N HCl and once with distilled water. To eval-
uate osteogenic diﬀerentiation, cells were ﬁrst stained for Alkaline
Phosphatase (ALP) at room temperature in the dark for 45 min
using a solution containing Fast Violet B salts with 4% (v/v) naph-
tol AS-MXphosphate alkaline solution. Calciummineralizationwas
stained with 2.5% (w/v) silver nitrate at room temperature in the
presence of light for 30min. After staining, cells werewashed three
times with distilled water and then visualised under a Nikon Ti
Eclipse phase contrast microscope.
Colony forming unit ﬁbroblast (CFU-F) assay
Colony forming unit eﬃciency of hMSC before and after expan-
sion on the FC40/DMEM interface was determined employing a
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Figure 2.M2 cells seeded at 10 000 cells cm−2. Live/Dead staining (green – live and healthy cells, red – dead or damaged cells) of cells at day 2 in culture
on (A) TCPS, (B) FC40/DMEM interface. Immunocytochemistry staining of cells cultured on (C) TCPS and (D) FC40/DMEM interface. Nuclei staining with
DAPI (blue), actin ﬁlaments with Phalloidin (red) and focal adhesions with paxillin (Green). Scale bar represents 100 μm.
protocol previously developed.5 Brieﬂy, harvested hMSCs were
seeded at 10 cells cm−2 in T-25 ﬂasks and kept in culture in normal
growth conditions for up to 14 days. Complete medium changes
were done every 3–4 days. After 14 days, the colonies were ﬁxed
for 30 min at room temperature with 4% (v/v) para-formaldehyde
and then stained with 1% (w/v) Crystal Violet solution at room
temperature for 60 min. Colonies of 25 cells and higher were
then counted and CFU-F eﬃciency (%) was calculated using
Equation (5).
CFU − F Eﬃciency (%) =
( 250
Number of Colonies
)
· 100 (5)
Statistical analysis was performed by SPSS (IBM, USA) using
either paired-sample t-tests or two-way ANOVA. Results were
deemed to be signiﬁcant if P-value <0.05.
RESULTS ANDDISCUSSION
hMSCmorphology when cultured on the FC40/DMEM
interface
When inoculated in the FC40/DMEM system, hMSCs localized at
the interfacial area between the two immiscible liquids, at the
hydrophilic side of the interface. No cells were observed at the
hydrophobic side. The same behaviour was previously reported
in studies involving other cell types such as ﬁbroblasts.32,34 After
conditioning the interfacial area in the serum-containing DMEM
for at least 2 h before cell inoculation, hMSCs attached and
exhibited the typical spindle-like morphology characteristic to
MSCs, similarly to traditional plastic surfaces (Fig. 1). Moreover,
the cells remained viable (viability >90%) when cultured on the
FC40/DMEM interface with only a few dead cells, as seen by
Live/Dead staining and ﬂuorescence imaging. Live and healthy
cells aregreenwith anelongatedﬁbroblast-likemorphology,while
dead or damaged cells are rounded and are stained red (Fig. 2(A)
and (B)). In addition, immunostaining of the actin ﬁlaments and
the focal adhesion protein, paxillin was performed to assess if
any changes in hMSC morphology or cell–matrix interactions
occur when cultured on the FC40/DMEM interface compared with
TCPS. However, in both cases, the hMSCs appeared well spread
with accumulated punctate paxillin around the nucleus and dis-
tinct actin stress ﬁbres around the peripheral edges, as shown in
Fig. 2(C) and (D) for M2 cell line and in Supplementary Fig. 1 for M0
cell line.
hMSC growth on the ﬂexible liquid/liquid interface
M2 cells were expanded on the ﬂexible FC40/DMEM interface and
kept in culture for up to 7 days. In parallel, M2 cells at the same
passage number were cultured on traditional solid substrates pro-
vided by TCPS and kept in culture for the same time period. At
day 3 in culture, no signiﬁcant diﬀerence was observed in cell
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Figure 3.M2 hMSC donor line growth kinetics over 7 days in culture on the FC40/DMEM interface compared to TCPS. Shown as (A) Speciﬁc growth rate,
(B) fold increase, (C) doubling time. Error bars represent the standard deviation of two independent experiments. Statistical analysis by paired-sample
t-test * P< 0.05; ** P< 0.005; (D) Unwanted cell sheet detachment and folding at day 6 in culture resulting in hMSC aggregates. Scale bar represents
500 μm.
growth on the two tested substrates. As such, a 1.33± 0.26-fold
increase was achieved on the FC40/DMEM interface compared
with 1.36± 0.11-fold increase when cultured on TCPS (Fig. 3(B)).
Moreover, it was observed that the growth kinetics were sim-
ilar with a speciﬁc growth rate of 0.091± 0.063 day−1 in the
FC40/DMEM system compared with 0.102± 0.025 day−1 on TCPS
(Fig. 3(A)). In addition, the percentage of EdU-positive cells indi-
cating the number of proliferative hMSCs at day 3 in culture was
slightly higher when cultured in the FC40/DMEM system com-
pared with TCPS, as shown in Fig. 4. However, by day 7 in cul-
ture, the ﬁnal fold expansion increase was 2.77± 1.01 on the
FC40/DMEM interface, but 2.5 times higher on the traditional TCPS
(p< 0.005) (Fig. 3(B)). The same behaviour was seen in the growth
kinetics of M2 hMSCs on the two substrates: a speciﬁc growth rate
of only 0.14± 0.05 day−1 was achieved in FC40/DMEM, 2 times
lower than the speciﬁc growth rate on TCPS for the same culture
period (P< 0.05). In addition, a signiﬁcant increase (P< 0.05) in
doubling times was found when cultured in the two-phase sys-
tem, 134.4± 49.6 h compared with culture on TCPS, 59.7± 1.6 h
(Fig. 3(C)).
Lower cell yields when cultured on the perﬂuorocarbon/DMEM
interfaces have previously been found.32,34 However, diﬀerent
cell types and even perﬂuorocarbons were used and to the best
of our knowledge, no previous studies have been done using
hMSCs or stem cells to investigate cell attachment and growth in
a perﬂuorocarbon/DMEM two-phase system. Moreover, hMSCs as
deﬁned by the ISCT criteria36 are adherent cells that preferentially
adhere to surfaces such as TCPS. In addition, it has been found
that when cultured on soft polyacrylamide gels that mimic the
elasticity of bone marrow and fat tissues, bone marrow-derived
hMSCs became quiescent; however, they resumed proliferation
once replated on TCPS.36 On the contrary, despite the lower cell
growth rates calculated when grown in the FC40/DMEM sys-
tem, we found that bone marrow-derived hMSCs attached and
proliferated on the FC40/DMEM interface. The lower cell yields
measured at the end of the culture could be a result of unwanted
cell sheet detachment and folding, resulting in the formation
of hMSC aggregated areas as seen in Fig. 3(D). As the interface
becomes populated with cells, the protein layer deposited on the
interface together with the extracellular matrix produced by the
cells becomes stretched and deformed resulting in unwanted cell
sheet detachment and folding and the formation of hMSC aggre-
gates. Depending on the size of aggregates formed, it is believed
that the proliferation capacity of the cells becomes reduced,38–40
thus possibly explaining the lower cell yields obtained at the end
of culture in the FC40/DMEM system.
To investigate the cell growth rates further, nutrient usage
and metabolite production during culture on the two diﬀer-
ent substrates was measured by spent medium concentration
analysis for glucose, lactate and ammonia. Statistical signiﬁcance
was assessed by two-way ANOVA. When cultured on both sub-
strates, glucose consumption increased signiﬁcantly with time in
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Figure 4. Representative ﬂuorescent images of M2 cells cultured for 3 days on (A) TCPS and (B) FC40/DMEM interface after being pulsed with EdU for
the last 24 h culture. Scale bars represent 100 μm. (C) Percentage of cells entering S-phase as quantiﬁed by EdU staining. Data expressed as Mean± SD;
N> 300 nuclei counted.
culture (P< 0.0001), however, no signiﬁcant diﬀerence (P> 0.05)
was found in glucose consumption when M2 cells were cultured
on the two substrates for 7 days (Fig. 5(A)). On the other hand, lac-
tate production also increased signiﬁcantly with time in culture in
both scenarios (P< 0.0001), however, lactate production was sig-
niﬁcantly higher (P< 0.05) when the M2 cells were cultured on
TCPS compared with the FC40/DMEM interface (Fig. 5(B)).
Moreover, the estimated yield of lactate from glucose
over the entire culture period was found to be 2.04± 0.25
mollactate/molglucose and 1.92± 0.12 mollactate/molglucose, respec-
tively, with no signiﬁcant diﬀerence when cultured on the
FC40/DMEM interface or TCPS (P> 0.05), respectively (Fig. 5(C)).
The yield of lactate to glucose represents a measure of how
eﬃciently cells metabolize glucose into energy. As such, there
are two possible metabolic pathways for glucose consumption
and these are either oxidative phosphorylation yielding 30 to
38 moles of ATP per mole of glucose or anaerobic glycolysis
which yields 2 moles of lactate from one mole of glucose.41,42
The calculated Ylac/glc values of around 2 mol/mol at the end
of culture suggested that the preferred metabolic pathway was
the anaerobic glycolysis when cultured on either of the tested
substrates. However, when looking at the lactate from glucose
yield produced at diﬀerent time points during culture, it was
found that actually a combination of oxidative phosphorylation
and anaerobic glycolysis was involved in glucose metabolism.
As such, regardless of the tested substrate, at the beginning
of the culture, at lower cell growth rates, the cells consumed
glucose in a more eﬃcient manner for energy production, as
suggested by the Ylac/glc values closer to 1 mol/mol (Fig. 5(C)).
Despite the lower cell numbers at the beginning of the culture,
the high energy produced by the cells is not used for cell growth
alone, but also for basic cell maintenance functions.42,43 The slight
increase in the Ylac/glc values at day 3 in culture suggesting lower
energy production rates could be attributed to the accumulation
of metabolites and consumption of nutrients, while the decrease
in Ylac/glc and the more eﬃcient energy production from glucose
after 3 days in culture could be possibly attributed to the partial
medium exchange done at day 3.
Another parameter that was measured during the culture on
the two substrates was ammonia production. Ammonia is mainly
released by metabolic deamination of glutamine to glutamate
and conversion of glutamate to 𝛼-keto-glutarate.44 Ammonia can
also be released by spontaneous decomposition of L-glutamine.
However, this cannot be the case here as we use a stable form of
glutamine in our cultures represented by ultra-glutamine. Several
previous studies have suggested that ammonia build-up in the
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Figure 5. Nutrient and metabolite ﬂux of hMSC M2 donor cell line expanded over 7 days on the FC40/DMEM interface and traditional TCPS. (A) Speciﬁc
glucose consumption rate; (B) Speciﬁc lactate production rate and (C) Yield of lactate from glucose. Error bars represent the standard deviation of two
independent experiments.
medium could potentially have a growth inhibitory eﬀect at rela-
tively low concentrations. For example, a concentration of approx-
imately 3mmol L−1 of ammoniawas found to be growth inhibitory
for goat-sourced MSCs.42 As such, another possible explanation
for the lower cell growth rates when cultured on the ﬂexible
liquid/liquid interface might be the accumulation of ammonia.
However, this was not the case here as the highest ammonia
concentration recorded at the end of culture was 0.27 mmol L−1.
Eﬀect of perﬂuorocarbon recyclability on hMSC proliferation
on the FC40/DMEM interface
One of themajor advantages of using perﬂuorocarbons as cell cul-
ture systems could be the ability to recover and recycle them.30
This beneﬁt could have great implications in the large scale
by reducing manufacturing costs. However, the ﬁrst thing to
test was the eﬀect of recovering and recycling the perﬂuoro-
carbon, as well as repeated sterilisation on hMSC attachment
and growth. Filter-sterilised, unused perﬂuorocarbon was referred
to as FC40fresh, while previously used, recovered and recycled
ﬁlter-sterilised perﬂuorocarbon was referred to as FC40recycled. As
such, hMSCswere seeded as before at 5000 cells cm−2 on the inter-
faces created in the FC40fresh/DMEM and FC40recycled/DMEM sys-
tems and kept in culture for up to 6 days. To account for donor
variability,45,46 three hMSC lines originating from three diﬀerent
donors (nomenclature presented in Supplementary Table 1) were
employed for this part of the study.
Regardless of the cell line used, hMSCs maintained their
cell morphology when cultured on either FC40fresh/DMEM or
FC40recycled/DMEM interfaces. Figure 6(A) shows representative
images for one of the selected hMSC lines (i.e. M2 cell line). Images
showing no evident diﬀerence in M0 and M4 cells morphology
when cultured on either fresh or recycled FC40/DMEM interface
are presented in Supplementary Fig. 2. Moreover, independently
of the cell line used, there was no signiﬁcant diﬀerence in hMSC
growth on either fresh or recycled FC40/DMEM interface (Fig. 6(B)).
No signiﬁcant diﬀerence was found in the speciﬁc glucose con-
sumption rates (Fig. 6(C)) or the speciﬁc lactate production rates
(Fig. 6(D)) of any of the three hMSC lines tested. In addition, at the
end of the culture, no signiﬁcant diﬀerencewas found in the calcu-
lated Ylac/glc values and moreover, the values of around 2 mollactate
/molglucose suggested that the preferred metabolic pathway of all
hMSC lines tested was the anaerobic glycolysis when cultured
on either of the tested substrates (Fig. 6(E)). These ﬁndings of no
signiﬁcant diﬀerences in cell growth on the liquid/liquid interfaces
madewith either fresh or recovered and recycled perﬂuorocarbon
could have major implications for the production costs at large
scales as a result of the recoverability and recyclability of the
perﬂuorocarbon. Also, donor variability did not seem to have
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Figure 6. Data for culturing on the FC40fresh/DMEM or FC40recycled/DMEM interfaces after 6 days (A) Representative phase contrast images of M2 cell
morphology. Scale bar represents 500 μm. Quantitative data for M0, M2 and M4 donor cell lines. (B) Fold increase; (C) speciﬁc glucose consumption rate,
(D) speciﬁc lactate production rate and (E) yield of lactate from glucose. Error bars represent the standard deviation of two independent experiments.
an impact on cell attachment and growth on either the fresh or
recycled FC40/DMEM interfaces and the growth proﬁles of the
selected hMSC lines on the FC40/DMEM interfaces were similar
to traditional TCPS when cultured as monolayers, with M0 being
the fastest growing and M4 being the slowest growing as found
previously by us.2
Post-expansion characterisation
hMSC characterisation was performed post-expansion at the
FC40/DMEM interface to ensure that the expansion on such a
substrate did not have a detrimental eﬀect on the hMSC identity
and quality. As such, the International Society of Cellular Therapy
(ISCT) criteria were applied.36 Post-expansion characterisationwas
performed for all three hMSC lines cultured on the FC40/DMEM
interface. A representative example of conformance to the ISCT
criteria is shown for the M2 cell line pre- and post-expansion in
Fig. 7. hMSCs adhered to TCPS post-harvest and post-expansion
for 6 days on the FC40/DMEM interface and exhibited similar
cell morphologies to pre-expansion (Fig. 7(A)). Moreover, the M2
hMSCs diﬀerentiated down the adipogenic (Fig. 7(B)), osteogenic
(Fig. 7(C)) and chondrogenic (Fig. 7(D)) lineages, both pre- and
post-expansion on the FC40/DMEM interface. The stiﬀness of
the surface on which MSCs are cultured is known to aﬀect
their lineage potential,47 however, as assessed by histology, the
brief culture period on the ‘soft’ FC40/DMEM interface has not
aﬀected the ability of the MSCs to diﬀerentiate into any of the
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Figure 7. Pre- and post-expansion of hMSC M2 cell line characterisation. (A) Cell morphology. Scale bars represent 500 μm. Tri-lineage diﬀerentiation: (B)
adipogenesis (scale bar 100 μm), (C) osteogenesis (scale bar 500 μm) and (D) chondrogenesis (scale bar 500 μm). Multi-parameter ﬂow cytometry analysis
showing dual gating of CD73, CD90, CD105, CD34 and HLA-DR for M2 hMSCs (E) pre-expansion and (F) post-expansion.
trilineages once replated back onto TCPS. Figure 7(E) and (F) show
the pre-expansion and post-expansion immunophenotype of
hMSCs, respectively. In both cases, the co-expression of positive
cell surface markers (e.g. CD73, CD90 and CD105) were greater
than 97%, while the expression of the negative markers (e.g.
CD34, HLA-DR) was found to be below 2%, in accordance with
the ISCT criteria for identifying the MSC immunophenotype.36
Similarly, the other tested hMSC lines, M0 and M4, retained the
same cell morphology as seen on TCPS after expansion for 6
days on the ﬂexible FC40/DMEM interface (Supplementary Fig. 2).
Moreover, post-expansion, the M0 and M4 cells also retained their
diﬀerentiation potential down the adipogenic and osteogenic
lineages, demonstrated the co-expression of the positive cell
surface markers, CD73, CD90 and CD105 and lacked the expres-
sion of the negative markers, CD34 and HLA-DR (Supplementary
Figs 3 and 4).
No signiﬁcant diﬀerencewas found in hMSC growth in either the
FC40fresh/DMEM or FC40recycled/DMEM systems with possible cost
implications at larger scales. However, the successful development
of hMSCmanufacturing system is deemed successful if cell quality
and identity remain intact.5,48 As such, it was imperative to deter-
mine if hMSC identity and quality were aﬀected by the perﬂuoro-
carbon recycling step. Figure 8(A) and (B) show themultiparameter
ﬂow cytometry analysis of harvested M2 cells after 6 days culture
in the two-phase systems when using either fresh or recycled
perﬂuorocarbon, demonstrating the co-expression and lack of
expression of the cell surface markers panel recommended by the
ISCT. Moreover, the hMSCs retained their diﬀerentiation poten-
tial post-expansion from both phase systems, FC40fresh/DMEM
(Fig. 8(C) and FC40recycled/DMEM (Fig. 8(D)), respectively.
Colony forming unit potential has been previously highlighted
as an important hMSC quality parameter49 and it has been shown
to deteriorate in certain conditions.50,51 Figure 8(E) shows the
colony forming unit-ﬁbroblast (CFU-F) eﬃciency of the M0 and
M2 cell lines when cultured on either TCPS or the FC40fresh/DMEM
or FC40recycled/DMEM interfaces. No signiﬁcant diﬀerence was
found in the CFU-F eﬃciency of M0 line when cultured in either
FC40fresh/DMEM or FC40recycled/DMEM systems. However, a signiﬁ-
cant diﬀerence (P< 0.05) was found in the CFU-F eﬃciency of M2
line when expanded on the two substrates tested (Fig. 8(E)). This
diﬀerence could possibly be attributed to donor variability and be
related to cell growth kinetics.
CONCLUSIONS
The liquid/liquid system tested here is a promising candidate
for the development of novel stem cell expansion systems. The
presence of cells on the hydrophilic side of the ﬂexible interface
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Figure 8. Post-expansion characterisation after 6 days of M2 hMSCs. Multiparameter ﬂow cytometry (A) FC40fresh/DMEM and (B) FC40recycled/DMEM.
Diﬀerentiation potential: adipogenesis (Scale bar 100 μm) and osteogenesis (Scale bar 500 μm) (C) FC40fresh/DMEM and (D) FC40recycled/DMEM system.
(E) Colony forming unit-ﬁbroblast (CFU-F) eﬃciency for M0 and M2 lines. Data expressed as Mean± SD (N= 6).
leads to the development of a scalable enzyme-free harvesting
method for cell sheet engineering. Moreover, cell harvest from
the proposed system could be performed without the use of
enzymes by simply aspirating, centrifuging or ﬁltering the inter-
face resulting in the recovering of cells with intact membrane
proteins. The proposed system is simple, ready-to-use and does
not require any modiﬁcation or coating in order to support MSC
attachment andproliferation.Moreover,MSCs culturedon theﬂex-
ible interface for up to 7 days retained their potency and iden-
tity post-expansion. In addition, the FC40/DMEM system can be
employed at larger scales by dispersing the perﬂuorocarbon into
the growth medium in the form of droplets that act as ‘liquid
microcarriers’ for cell expansion.23 In addition, this system has the
potential to be cost-eﬀective when employed at larger scales as a
result of theperﬂuorocarbon recoverability and recyclability. There
was no signiﬁcant diﬀerence in cell attachment, growth or even
cell quality when cultured on the interface prepared with recy-
cled perﬂuorocarbon compared with fresh, not previously used
perﬂuorocarbon. Previous reports suggested that MSCs become
quiescent when cultured on a soft gel-like substrate with resum-
ing proliferation when transferred to TCPS. As such, MSC prolifer-
ation on the FC40/DMEM interface was unexpected. As a result,
the proposed FC40/DMEM system could also ﬁnd applicability for
cell–substrate interactions or cell migration studies.
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